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Background: Obstructive Jaundice (OJ) is associated with a signiﬁcant risk of developing acute renal
failure (ARF). The involvement of oxidative stress in the development of cholestasis has been demon-
strated in different experimental models. However, its role in the morbidity of human cholestasis is far to
be elucidated. The aim of the study was the evaluation of oxidative stress markers in blood from patients
with OJ and its relation to complications and benign/malignant evolution of cholestasis. Methods: A
prospective cross-sectional study of 105 patients with OJ and 34 control subjects were included. Several
markers of liver function and oxidative stress, such as lipoperoxides (LPO), as well as reduced glutathione
(GSH), catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities were
assessed. Results: The patients with OJ showed a marked increase in plasma levels of LPO, SOD and GSH,
while GSH-Px levels were decreased. The increase in lipid peroxidation products and the depletion of
SOD activity in blood were also related to renal dysfunction. The highest level of LPO was associated with
malignant etiology of the disease. The logistic regression analysis showed that the age of the patient and
the levels of LPO in blood were predictors of renal dysfunction in OJ patients. Conclusions: This study
demonstrates a correlation between oxidative stress and renal dysfunction patients with OJ.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The obstruction of extrahepatic biliary tract results in the di-
latation of bile ducts with an accumulation of hydrophobic bile
acids in hepatocytes. The toxic biliary products, such as gly-
cochenodeoxicholate, as well as neutrophil migration promote the
generation of oxygen-free radicals, unbalancing antioxidant status
in the hepatic parenchyma [1]. Exogenous regulation of oxidative
stress ameliorates liver injury induced by experimental cholestasis
[2–4]. The pathogenesis of OJ involves a systemic alteration that
affects different extrahepatic tissues. An increase in lipoperoxida-
tion products is observed in extrahepatic tissues, including kidney
and brain, in animals subjected to OJ [5,6].B.V. This is an open access article u
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ez-Cecilia).Acute renal failure is a signiﬁcant adverse outcome of OJ, ob-
serving rates of 6–18% [7], and is associated with a signiﬁcant
morbidity and postoperative mortality [8,9]. The administration of
melatonin reduces lipid oxidation in kidney during experimental
OJ [10]. Hypotension and sepsis, secondary to depletion of extra-
cellular ﬂuid and myocardial dysfunction has proven to be relevant
in the development of kidney disease in cholestatic patients [11–
19]. However, the role of oxidative stress during renal complica-
tions of OJ has not been studied in detail.
The main objective of the present study was to assess the
correlation between the alteration of oxidative stress biomarkers
in blood and the presence of renal failure in patients with OJ.2. Methods
2.1. Design of study
The study was designed as a prospective cross-sectional ob-
servational study. 105 patients with OJ were enrolled andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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height, and body mass index. The patients were included over a
period of 26 months. Inclusion criteria were OJ of benign or malign
ethiology, levels of conjugated bilirrubin higher than 2 mg/dl or
total bilirrubin higher than 3 mg/dl, biochemical cholestatic pat-
tern, ultrasound evidence of extrahepatic bile duct dilatation
higher than 12 mm and intrahepatic higher than 4 mm. Exclusion
criteria were acute cholangitis, parenchymal liver disease, gastro-
intestinal hemorrhage, prior or concomitant intravenous ﬂuid
therapy, heart failure or chronic renal failure, undernourished
patients, and treatment with diuretics, antihypertensives, cimeti-
dine or trimethoprim. Informed consent was obtained from all
participants.
The study was approved by the Ethical Committee for Clinical
Research of the Institution.
2.2. Biochemical measurements
Biochemical and oxidative stress parameters were measured on
patients peripheral blood samples while admission to hospital.
Same determinations were performed in control subjects under
similar conditions to baseline measurements in patients with ob-
structive jaundice. The levels of direct and total bilirubin, sodium,
potassium, AST, ALT, alkaline phosphatase (AP), albumin and total
protein were performed with Cobas Integra Roche-400 analyzer
(Roche Diagnostics Ltd., Switzerland). Renal function was esti-
mated by the modiﬁed formula known as MDRD (Modiﬁcation of
Diet in Renal Disease) [20]. Renal impairment was considered
when the glomerular ﬁltration rate (GFR) value was r70 ml/min
(1.73 m2). GFR was measured according to the MDRD using the
following the formula:
= × [ ]− × ( )
– × ( ) × ( )
MDRD 186 creatinine, mg/dl 1.154 age
0.203 0.742 in women 1.212 if black population
2.3. Oxidative stress markers
The markers of oxidative stress were assessed in plasma ob-
tained after blood centrifugation at 3000 g for 5 min at 4 °C.
Samples were stored at 80 °C until measurements.
LPO and GSH were determined using commercial assays (LPO-
586 and GSH-400, Bioxytech SA, Oxis International, Portland, OR,
USA). CAT and SOD were measured according to Aebi [21] and Sun
[22] methods, respectively. GSH-Px was measured according to
Flohe and Gunzler [23] method. The values were measured using a
plate reader spectrophotometer Shimadzu UV-1603 (Shimadzu,
Kyoto, Japan).
2.4. Statistical analysis
Results are expressed as mean7standard deviation (SD).
Comparisons between two groups were performed using Student's
t test for unpaired groups or Mann–Whitney. Comparisons be-
tween three groups were performed using ANOVA analysis fol-
lowed of post-hoc Kruskal–Wallis test. Comparisons between
proportions were performed by chi-squared test. Correlations of
variables were evaluated with Pearson coefﬁcient or Spearman rho
coefﬁcient. Multivariate analysis was performed to identify factors
associated with renal dysfunction. The main variables considered
were: etiology of jaundice, age, duration of jaundice, bilirubin,
sodium, potassium, AST, ALT, AP, albumin, total protein, LPO, GSH,
GSH-Px, SOD, CAT. Linear and logistic regression were performed
with the estimated renal function by MDRD. Stepwise method was
used excluding variables with PZ0.15 (Student's t statistic for
linear regression and Wald statistic for logistic regression).3. Results
3.1. Oxidative stress in patients with OJ. Correlation with renal
insufﬁciency
Table 1 shows general demographic and biochemical char-
acteristics of the Control and OJ groups. OJ patients (n¼105) were
distributed in 67 men (64%) and 38 women (36%), with mean age
of 69712.8 years old (15–93 years) (Table 1). The levels of per-
ipheral LPO, GSH and SOD concentration were signiﬁcantly higher
in the group of patients with OJ compared to control subjects
(p¼0.0001) (Table 1). By contrast, levels of GSH-Px showed a
signiﬁcant decline (p¼0.0001) (Table 1).
A strong positive correlation was found between levels of
conjugated bilirubin and LPO in plasma (r¼0.744, p¼0.0001)
(Fig. 1).
The creatinine clearance in control subjects (98731.1) was
signiﬁcantly higher than in OJ patients of benign ethiology
(56725.9, p¼0.031). There were no statistically signiﬁcant dif-
ferences with creatinine clearance in patients with malign
ethiology (72735.2, p¼0.199). The GFR of control subjects
(104738.2 ml/min) was higher than in OJ patients of benign
ethiology (84737.9 ml/min, p¼0.010) with a moderate non sta-
tistically signiﬁcant improvement in the malign ethiology
(116793.3 ml/min, p¼0.184). Renal failure was present in 32% of
the patients, whereas it was only observed in 6% of controls. The
presence of renal insufﬁciency in patients with OJ was associated
with higher levels of total bilirubin (p¼0.002), as well as an in-
crease in serum levels of LPO (p¼0.017) and GSH (p¼0.017) (Ta-
ble 2). By contrast, the levels of SOD showed a decrease in patients
with renal impairment (p¼0.044) (Table 2). There were no sta-
tistically signiﬁcant differences in the levels of GSH-Px and CAT
levels (Table 2).
A weak negative correlation was found between plasma levels
of LPO and the GFR (r¼0.303, p¼0.001) (Fig. 2).3.2. Analysis of patients with OJ according to the benign/malign
ethiology
There were not signiﬁcant differences among the percentage of
gender (men) in patients with benign (n¼33, 31.5%) and malign
(n¼72, 68.5%) cholestasis (Table 3). The increased levels of total
(20711.5 vs 1277.4, p¼0001) and direct bilirubin (1679.6 vs
976.0, p¼0001), and AP (7577554.3 vs 5287577.3, p¼0.005) in
blood from patients with OJ of malign vs benign etiologies re-
spectively, was probably due to the longer evolution period of the
disease (mean duration for jaundice 18 vs 9 days) (Table 3). LPO
levels were also higher in malignant etiology group. (6037202.0
vs 4737144.8 nmol/l) (p¼0.0001) (Table 3).3.3. Multiple linear regression analysis
Different variables such as age, duration of jaundice, bilirubin,
sodium, potassium, AST, ALT, albumin, total proteins, GSH, SOD
and CAT were eliminated from the model using the multiple F
partial test (F¼0.2764, p¼0.735; freedom degree¼12.53). The
multiple linear regression analysis for GFR estimated by the MDRD
formula fulﬁlled the conditions of proper application such as lin-
earity of independent variables, no co-linearity and independence
among them, normality of residues and homoscedasticity of
variances.
The linear adjusted equation for the GFR in OJ patients was:
Table 1
Demographic characteristics and biochemical parameters of the cohorts.
Control Jaundiced pn
Gender (%, men) 64% 71% 0.607
Age (years) 57716.5 69712.8 0.001
Weight (Kg) 73713.9 73.3717.5 0.839
Height (cm) 16279.4 161715 0.923
Systolic blood pressure (mmHg) 122712.8 122.3720 0.730
Diastolic blood pressure (mmHg) 73710.6 70711.9 0.224
Temperature (°C) 3770.5 3670.4 0.634
Total Bilirubin (mg/dl) 0.50070.2 17.5711.00 0.001
Direct Bilirubin (mg/dl) 0.23070.21 13.979.25 0.001
AP(U/L) 66727.1 6847569.2 0.001
GGT (U/L) 687106.6 6697537.5 0.001
LPO (nmol/L) 163782.8 5637195 0.001
GSH (nmol/L) 1.8071.000 10.775.3 0.001
GSH-Px (U/L) 22.878.50 15.1711.80 0.001
SOD (U/L) 15.1711.100 168795.0 0.001
CAT (U/L) 3.872.10 4.874.90 0.124
n Level of statistical signiﬁcance obtained with Student's t test or Mann–
Whitney, as appropriate.
Table 2
Direct bilirubin and oxidative stress parameters in blood from patients with OJ
according to renal function.
Normal** Function
GFRZ70 (ml/min)
Impairmentnn
GFRo70 (ml/min)
pn
Direct Bilirubin
(mg/dL)
8.91 (9–12) 14.53 (10–24) 0.002
LPO (nmol/L)) 428.76 (46–211) 588.03 (79–289) 0.017
GSH (nmol/L) 7.67 (5–60) 11.01 (5–71) 0.012
GSH-Px (U/L) 17.53 (12–88) 14.78 (5–15) 0.497
SOD (U/L) 145.48 (62–488) 99.74 (58–196) 0.044
CAT (U/L) 4.75 (5–16) 3.96 (2–90) 0.541
nn The results were expressed with the median and the range values in par-
enthesis.
n Level of statistical signiﬁcance obtained with Student's t test or Mann–
Whitney, as appropriate.
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+ [ ]−( )−( )
+ ( − )
MDRD 67.74 29.57 if benign etiology
77.06 if malignant etiology AP 0.03 0.07 LPO
2.22 GSH Px
The adjusted coefﬁcient of determination (R2) was 0.171, and F
value was 5.485 (p¼0.0001). The statistical associative model in-
dicated that 1 nmol/L increase of LPO will decrease MDRD esti-
mation in 0.07 ml/min (IC95¼0.01). In addition, 1 U/L increase of
GSH-Px will increase MDRD estimation in 2.2 ml/min (IC95¼1.1).
3.4. Logistic regression analysis
Different variables (etiology, duration of jaundice, bilirubin,
sodium, potassium, AST, ALT, AP, albumin, total proteins, GSH,
GSH-Px, SOD and CAT) were eliminated from the model. The lo-
gistic regression analysis demonstrated that risk factors for renal
dysfunction followed the equation:
= − + ( ) + ( )Z 5.791 0.044 age 0.003 LPO
The value of the likelihood ratio test was 12.532 (p¼0.002) and
Hosmer–Lemeshow C value was 5.604 (p¼0691). The statistical
associative model indicated that the risk of renal dysfunction
measured by MDRD was 1.05 times higher each year of age (5% risk
increase per year). Moreover, for every increase of 10 units of LPO,
the risk of renal dysfunction was 1.031 times greater (3% risk
increase).Fig. 1. Correlation between serum bilirubin and LPO4. Discussion
Redox imbalance associated with OJ has been extensively de-
monstrated in experimental animal models [24,25]. However,
there is a signiﬁcant lack of evidence for this association in hu-
mans. Assimakopoulos et al. showed an alteration of oxidative
status in intestinal tissue that may underlie the systemic en-
dotoxemia in OJ patients [6]. Montilla et al. showed an exacerba-
tion of hepatic lipoperoxidation with reduction of antioxidant
status induced by ligature of extra-hepatic biliary duct in rats [3].
The present study demonstrated that lipoperoxidation markers in
blood are increased in patients with OJ in relation to the renal
dysfunction and the benign or malign ethiology.
The neoplastic origin of the OJ was related to a longer evolution
of the disease than that observed in the benign cholestatic etiol-
ogy. In concordance with previous studies [26–29], the progres-
sion of the disease was related to the progression of markers of
cholestasis (Table 3).
The evidences for the correlation between oxidative stress,
renal dysfunction and progression of OJ were reinforced in the
present study. We observed a drastic reduction of renal function in
patients with OJ of benign origin with a mild not signiﬁcant re-
covery in patients with malignant etiology. Overall, renal failure
was present in 32% of the patients, whereas it was only observed
in 6% of control subjects. A previous clinical study had reported a
10% renal disfunction not related to the etiology in a cohort of 55
patients with OJ [30]. This higher rate in our study was probably
related to the use of higher threshold for considering renal in-
sufﬁciency (GFR less than 70 ml/min instead of 50 ml/min), the
election of a more accurate method to measure kidney function,
increased number of patients and their distribution according toconcentration in blood from patients with OJ.
Fig. 2. Correlation between LPO concentration in blood and GFR in patients with OJ.
Table 3
Demographic characteristics and biochemical parameters of the cohorts distributed
according to benign and malignant origin.
Control (n¼34) Benign etiol-
ogy (n¼33)
Malignant
etiology
(n¼72)
p*
Gender (%, men) 70% 61% 71% 0.533
Age 57716.5 66718.0 7079.4 0.013a
0.001b
0.818c
Weight (Kg) 73713.9 74718.3 73717.2 0.906
Height 16279.4 16379.3 160717.4 0.978
Systolic blood
pressure
(mmHg)
122712.8 121722.2 123720.1 0.938
Diastolic blood
pressure
(mmHg)
73710.6 68712.9 70711.6 0.435
Temperature (°C) 3770.5 3670.4 3670.4 0.889
Jaundice dura-
tion (days)
0 9.175.20 1878.6 0.001c
Total Bilirubin
(mg/dl)
0.50070.2000 11.777.40 20.2711.50 0.001a
0.001b
0.001c
Direct Bilirubin
(mg/dl)
0.23070.2100 9.076.00 16.279.60 0.001a
0.001b
0.001c
AP(U/L) 66727.1 5287577.3 7577554.3 0.001a
0.001b
0.005c
GGT (U/L) 687106.6 6387548.2 6837535.7 0.001a
0.001b
0.791c
LPO (nmol/L) 163782.8 4737144.8 6037202 0.001a
0.001b
0.001c
GSH (nmol/L) 1.871.00 9.574.80 11.275.40 0.001a
0.001b
0.226c
GSH-Px (U/L) 22.878.50 15.074.20 15.1714.00 0.001a
0.001b
0.170c
SOD (U/L) 15.1711.10 52752.6 2207287.8 0.001a
0.001b
0.281c
CAT (U/L) 3.874.10 4.573.30 5.075.50 0.250a
0.127b
0.974c
a Comparison between control and benign cohorts.
b Comparison between control and malignant cohorts.
c Comparison between benign and malignant cohorts.
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patient cohort. As glomerular ﬁltration rate decreases with aging,
the authors can not exclude a selection bias. This will be discussed
later. The oxidative stress markers showed a more intense lipid
peroxidation in plasma from patients with OJ and renal dysfunc-
tion (Table 2). The alteration of GFR (GFRo 70 ml/min) was re-
lated to an increase of peripheral LPO and GSH, and a reduction of
SOD (Table 2).
Another key aspect of the study was the correlation between
oxidative stress markers and disease progression. Levels of total
bilirubin, direct bilirubin, AP and GGT were progressively in-
creased from benign to malignant evolution probably as a con-
sequence of the longer evolution of the disease (Table 3). In this
situation, the levels of LPO were much higher in blood from pa-
tients with OJ than in controls, reaching the highest levels in those
with malignant origin (p¼0.0001).
A strong positive correlation was observed between the levels
of lipoperoxides and bilirubin in blood (Fig. 1) which was in con-
cordance with previous reports showing the pro-oxidant capacity
of toxic bile acids [31]. The increased levels of LPO were associated
with a rise of GSH and SOD and reduction of GSH-Px in blood from
jaundiced patients with benign ethiology (p¼0.0001). Although
the tendency of blood levels of antioxidants (GSH and SOD) was to
increase in both groups of patients (benign and malign), the dif-
ference between OJ etiologies did not reach statistical signiﬁcance
(Table 3). The explanation may be related to the accumulative al-
teration of GSH, GSH-Px and SOD (expression or activity) in the
different compartment of the body (liver and extrahepatic tissue,
and blood cells) by the sustained oxidative stress in patients with
OJ of malignant origin. In fact, the progression of experimental
jaundice (14 and 21 days) paralleled the increase of LPO and he-
molysis, and reduction of total GSH content in blood from ob-
structed rats [32]. In this study, the level of GSH-Px in liver was
reduced throughout all the study [32].
Several experimental studies [32] have demonstrated a reduc-
tion of plasma and hepatic levels of GSH in OJ, which tend to re-
cover after therapeutic intervention. The plasma levels of GSH
were around 10 times higher in patients with OJ compared to
those observed in control subjects (Table 3). The interpretation of
this phenomenon may lie to the strong response of the body to
adapt to the conditions of oxidative stress increasing the synthesis
of GSH during cholestasis. As far as we know, our study is the ﬁrst
reporting GSH content in blood from patients with OJ. Data will be
useful to clarify the behavior of this antioxidant in regard to its
modulation in liver or intestine.
The multiple linear regression model showed that the benign
or malignant ethiology, AP, LPO and GSH-Px were related to renal
function in patients with OJ. This study demonstrated for the ﬁrst
D. Martínez-Cecilia et al. / Redox Biology 8 (2016) 160–164164time in humans the relationship between the increase of oxidative
stress markers during OJ and the associated renal failure. Renal
function was affected by the intensity of the biliary obstruction,
and the balance between LPO and antioxidant defenses. The fact
that age was not identiﬁed as affecting the glomerular ﬁltration
rate estimation counteracts the previously exposed idea of a pos-
sible selection bias.
The logistic regression analysis showed that the age of the
subjects and the levels of LPO in blood were predictors of renal
dysfunction in OJ patients. At this point we must consider that
glomerular ﬁltration rate decline with aging could express a sign
of normal senescence instead of a disease. Future researches
should consider different cut-off points for renal dysfunction by
stratifying by age groups.
Regarding redox imbalance, multivariate analysis overall con-
ﬁrmed the relationship between the oxidative markers in blood
and the intensity of OJ and renal dysfunction.
In conclusion, our study is the ﬁrst report showing in a large
series of patients that in situations of OJ, the reduction of GFR or
renal dysfunction is related to lipid peroxidation and alteration of
antioxidant status in blood. The progression of the disease char-
acteristic of malignant etiology was associated with an exacerba-
tion of lipid peroxidation.Acknowledgments
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